PPARs Mediate Lipid Signaling in Inflammation and Cancer

Lipid mediators can trigger physiological responses by activating nuclear hormone receptors, such as the peroxisome proliferator-activated receptors (PPARs). PPARs, in turn, control the expression of networks of genes encoding proteins involved in all aspects of lipid metabolism. In addition, PPARs...

Full description

Saved in:
Bibliographic Details
Main Authors: Liliane Michalik, Walter Wahli
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2008/134059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551928728387584
author Liliane Michalik
Walter Wahli
author_facet Liliane Michalik
Walter Wahli
author_sort Liliane Michalik
collection DOAJ
description Lipid mediators can trigger physiological responses by activating nuclear hormone receptors, such as the peroxisome proliferator-activated receptors (PPARs). PPARs, in turn, control the expression of networks of genes encoding proteins involved in all aspects of lipid metabolism. In addition, PPARs are tumor growth modifiers, via the regulation of cancer cell apoptosis, proliferation, and differentiation, and through their action on the tumor cell environment, namely, angiogenesis, inflammation, and immune cell functions. Epidemiological studies have established that tumor progression may be exacerbated by chronic inflammation. Here, we describe the production of the lipids that act as activators of PPARs, and we review the roles of these receptors in inflammation and cancer. Finally, we consider emerging strategies for therapeutic intervention.
format Article
id doaj-art-12cd5ddb2bd04c0e98a3454d24eca31f
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2008-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-12cd5ddb2bd04c0e98a3454d24eca31f2025-02-03T06:00:04ZengWileyPPAR Research1687-47571687-47652008-01-01200810.1155/2008/134059134059PPARs Mediate Lipid Signaling in Inflammation and CancerLiliane Michalik0Walter Wahli1Center for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, 1015 Lausanne, SwitzerlandCenter for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, 1015 Lausanne, SwitzerlandLipid mediators can trigger physiological responses by activating nuclear hormone receptors, such as the peroxisome proliferator-activated receptors (PPARs). PPARs, in turn, control the expression of networks of genes encoding proteins involved in all aspects of lipid metabolism. In addition, PPARs are tumor growth modifiers, via the regulation of cancer cell apoptosis, proliferation, and differentiation, and through their action on the tumor cell environment, namely, angiogenesis, inflammation, and immune cell functions. Epidemiological studies have established that tumor progression may be exacerbated by chronic inflammation. Here, we describe the production of the lipids that act as activators of PPARs, and we review the roles of these receptors in inflammation and cancer. Finally, we consider emerging strategies for therapeutic intervention.http://dx.doi.org/10.1155/2008/134059
spellingShingle Liliane Michalik
Walter Wahli
PPARs Mediate Lipid Signaling in Inflammation and Cancer
PPAR Research
title PPARs Mediate Lipid Signaling in Inflammation and Cancer
title_full PPARs Mediate Lipid Signaling in Inflammation and Cancer
title_fullStr PPARs Mediate Lipid Signaling in Inflammation and Cancer
title_full_unstemmed PPARs Mediate Lipid Signaling in Inflammation and Cancer
title_short PPARs Mediate Lipid Signaling in Inflammation and Cancer
title_sort ppars mediate lipid signaling in inflammation and cancer
url http://dx.doi.org/10.1155/2008/134059
work_keys_str_mv AT lilianemichalik pparsmediatelipidsignalingininflammationandcancer
AT walterwahli pparsmediatelipidsignalingininflammationandcancer